Cleveland Clinic and Mount Sinai say they will not administer controversial Alzheimer's drug

The Cleveland Clinic and Mount Sinai both will not administer Biogen's Aduhelm, they announced this week. The move comes after controversy surrounding the drug's FDA approval.

Source: the Mail online | Health - July 15, 2021 Category: Consumer Health News Source Type: news